Clinical Trial Update: Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures [Phase 3]

View source ↗

Summary

Open-label extension in pediatric patients with partial-onset seizures evaluating long-term safety and tolerability of pregabalin (Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsies
• Partial-onset Seizure

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Epilepsies, Partial | Phase 3 | Status: COMPLETED | Results posted: 2014-12-02